No Data
No Data
As of August 9, 2024, zhejiang east-asia pharmaceutical (605177.SH) has a total of 9,512 shareholders.
Zhejiang East-Asia Pharmaceutical (605177.SH) stated on its interactive platform on August 15th that the number of shareholders in the company was 9,512 as of August 9th, 2024.
As of July 31, 2024, the number of shareholders in zhejiang east-asia pharmaceutical (605177.SH) is 9,509.
Zhejiang East-Asia Pharmaceutical (605177.SH) stated on the interactive platform on August 8th that as of July 31, 2024, the number of shareholders in the company is 9509.
Zhejiang East-Asia Pharmaceutical (605177.SH): has cumulatively spent 54.99 million yuan to repurchase 1.89% of its shares and completed the repurchase.
On August 1st, Gelunhui reported that Zhejiang East-Asia Pharmaceutical (605177.SH) completed the repurchase of shares on July 31, 2024. This time, a total of 2,170,103 shares were repurchased through centralized auction trading, and the repurchased shares accounted for 1.8911% of the total share capital of the company (because the company's "East-Asia Convertible Bonds" were in the conversion period, the total share capital continued to change. As of July 31, 2024, the total share capital of the company increased to 114,753,335 shares). The highest transaction price was 32.68 yuan/share, and the lowest was 15.47 yuan/share. The total amount paid was 549 million yuan.
As of July 19, 2024, Zhejiang East-Asia Pharmaceutical (605177.SH) had 9,420 shareholders.
On July 22, Gelunhui reported that the number of shareholders of Zhejiang East-Asia Pharmaceutical (605177.SH) as of July 19, 2024, was 9,420.
As of July 10, 2024, zhejiang east-asia pharmaceutical (605177.SH) had 9,187 shareholders.
On July 11th, Gelunhui reported that as of July 10, 2024, zhejiang east-asia pharmaceutical had 9,187 shareholders on the interactive platform.
Zhejiang East-Asia Pharmaceutical (605177.SH) plans to distribute a dividend of 0.33 yuan per share for the 2023 fiscal year, with ex-rights and ex-dividends on July 4th.
Zhejiang East-Asia Pharmaceutical (605177.SH) announced that the proposed annual cash dividend per share for 2023 is 0.33 yuan (...)
No Data